Serina Therapeutics Inc (SER)
Healthcare
Biotechnology
2.00 $
-2.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Serina Therapeutics Inc (SER) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -4.6 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.9 | -1.0 | 0.1 | -1.6 | -8.0 | -3.0 | -4.6 | -4.3 | -3.8 | -3.9 | -6.0 | -4.6 | -18 | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.0 | 0.0 | 0.1 | 0.1 | 0.5 | 1.1 | 1.0 | 1.0 | 0.9 | 1.0 | 0.9 | 1.1 | 3.9 | |
| 0.1 | -0.1 | -0.3 | 0.5 | -4.8 | 1.1 | -0.2 | 0.5 | 0.7 | 1.4 | -1.1 | 0.5 | 1.5 | |
| 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | |
| -0.3 | -0.1 | -0.1 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | -0.1 | |
| – | – | – | – | – | 5.1 | 10 | 4.9 | 10 | 12 | 12 | – | – | |
| – | – | – | – | – | 0.0 | 0.1 | 0.0 | 0.0 | 4.9 | 0.0 | – | – | |
| 0.0 | 0.0 | 0.0 | 2.7 | 5.4 | 0.1 | 5.0 | 4.9 | 5.6 | 6.4 | 0.5 | 26 | 39 | |
| 0.0 | 0.1 | 7.2 | 1.1 | -2.6 | -2.9 | 0.4 | 0.6 | 1.8 | 2.6 | -5.6 | 21 | 20 | |
| -1.2 | -1.1 | 0.1 | -1.6 | -8.0 | -3.0 | -4.6 | -4.3 | -3.8 | -3.9 | -6.0 | -4.6 | -18 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.